Publications

Export 2 results:
Sort by: Author Title Type [ Year  (Desc)]
2019
Carvalho, LCR, Lourenco A, Ferreira LM, Branco PS.  2019.  Tofacitinib Synthesis - An Asymmetric Challenge, JAN 31. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. 2019:615-624., Number 4 Abstract

Tofacitinib is a Janus activated kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis and active psoriatic arthritis. Its synthesis normally involves long synthetic sequences due to the chirality associated to the piperidine ring. This review is a comprehensive analysis of the different synthetic methods used to prepare this active pharmaceutical ingredient (API), covering the related journal and patent literature.

2017
Feio-Azevedo, R, Costa VM, Ferreira LM, Branco PS, Pereira FC, Bastos ML, Carvalho E, Capela JP.  2017.  Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells, MAR 5. TOXICOLOGY LETTERS. 269:65-76. Abstract
n/a